Decipher Labs Limited (BOM:524752)
6.23
+0.18 (2.98%)
At close: Jun 17, 2026
Decipher Labs Revenue
In the fiscal year ending March 31, 2026, Decipher Labs had annual revenue of 142.75M INR, down -40.34%. Decipher Labs had revenue of 37.78M in the quarter ending March 31, 2026, a decrease of -13.53%.
Revenue
142.75M
Revenue Growth
-40.34%
P/S Ratio
0.44
Revenue / Employee
142.75M
Employees
1
Market Cap
62.92M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 142.75M | -96.54M | -40.34% |
| Mar 31, 2025 | 239.29M | -123.46M | -34.03% |
| Mar 31, 2024 | 362.75M | -166.41M | -31.45% |
| Mar 31, 2023 | 529.16M | -124.06M | -18.99% |
| Mar 31, 2022 | 653.22M | 97.60M | 17.57% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Vivanza Biosciences | 1.16B |
| Fabino Enterprises | 208.41M |
| Beryl Drugs | 188.20M |
| Brawn Biotech | 169.78M |
| Unjha Formulations | 157.49M |
| Colinz Laboratories | 61.36M |
| Ganga Pharmaceuticals | 28.28M |
| Emmessar Biotech & Nutrition | 24.07M |